Amy Law

Amy Law is the Director of Value & Evidence for RSV Vaccines at Pfizer, where they currently lead initiatives in health technology assessment. Previously, Law held several key positions including Director of Global Medical Research at Intercept Pharmaceuticals and Deputy Director of HEOR for both Oncology and Women's Health at Bayer Pharmaceuticals. Their career began as a Health Economics and Outcomes Research Fellow at Novartis, after which they worked as a Program Director in Medical Data Analytics at Roche Pharmaceuticals. Law's extensive experience in health economics and research spans over two decades.